Tobinworld to Shutter Schools

Tobinworld, an educational nonprofit for autistic and emotionally challenged children, plans to lay off more than 100 employees in December with the closing of several schools in Glendale.

Amgen Slashes Price for Repatha by 60 Percent

Amgen Inc. will distribute its cholesterol drug Repatha at a 60 percent lower list price as of Dec. 31.

Mission Hills Cancer Clinic Staff Join Union

City of Hope Mission Hills staff were among 170 City of Hope workers to join SEIU-United Healthcare Workers West, according to a statement from the union on Monday.

Arcutis Biotherapeutics Raises Nearly $95 Million in Series C Funding

Arcutis Biotherapeutics, a private immuno-dermatology drug development company in Westlake Village, has completed a $94.5 million Series C financing round.

Westlake Village BioPartners Takes Stake in Cancer Therapy Startup

Westlake Village BioPartners is one of seven investors to back ArsenalBio, a San Francisco-based immune cell therapy startup.

Kaiser Permanente Workers Ratify Four-Year Contract

SEIU-United Healthcare Workers West on Wednesday ratified a four-year agreement with Kaiser Permanente, according to a statement from the union.

Cerner Terminates 217 Workers as Relationship With Adventist Health Ends

Cerner Corp., a Kansas City, Mo.-based IT company for health care organizations, plans to terminate 217 employees at sites in Simi Valley and Glendale as a result of ending its business relationship with Adventist Health in November.

Hospitals Experience Staff Shortages Due to Fires

n the midst of the Saddleridge and Wendy fires, hospitals in the Santa Clarita, San Fernando and Antelope valleys remain open and look to make sure departments are adequately staffed, despite closures of major freeways.

Conejo Valley Clinic Receives AstraZeneca Grant

Westminster Free Clinic, a heart health clinic in Thousand Oaks, was one of 11 clinics in the U.S. to receive a grant from AstraZeneca HealthCare Foundation’s Connections to Cardiovascular Health program.

Beleaguered Sienna Seeks to Sell Laser Treatment

Sienna Biopharmaceuticals has filed a notification with the U.S. Food and Drug Administration seeking permission to sell its drug SNA-001, a topical pre-treatment for laser removal of light hair, according to a statement from the company on Monday.

Second Sight Receives $2.4 Million Grant for Depth Perception Technology

Second Sight Medical Products Inc. on Tuesday announced it received a $2.4 million, four-year grant from the National Institutes of Health to further development of the Orion Visual Cortical Prosthesis System.

Avita Medical Moves to Nasdaq From Over-The-Counter

Avita Medical Ltd., a medical device firm based in Melbourne, Australia with its U.S. headquarters in Valencia, on Monday announced its American depository shares have been approved to list on the Nasdaq.

Endonovo Appoints Strategic Advisor on Blood Vessel Research

Endonovo Therapeutics in Woodland Hills on Monday announced the appointment of Dr. William Li as strategic advisor to Chief Executive Alan Collier.

Motion Picture Television Fund Opens New Center

Woodland Hills’ Motion Picture Television Fund welcomed the Wise Adult Day Services Center to its Wasserman Campus.

Tease photo

Sienna Files for Chapter 11 Reorganization

Sienna Biopharmaceuticals, a clinical-stage biopharmaceutical company in Westlake Village, on Tuesday announced it has filed for Chapter 11 reorganization.